{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T17:34:11Z","timestamp":1793036051895,"version":"4.5.0"},"reference-count":28,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2009,8,18]],"date-time":"2009-08-18T00:00:00Z","timestamp":1250553600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neurogastroenterology Motil"],"published-print":{"date-parts":[[2010,1]]},"abstract":"<jats:p>\n                    <jats:bold>Abstract\u2002<\/jats:bold>\n                    Velusetrag (TD\u20105108) is a potent, selective high intrinsic activity serotonin 5\u2010HT\n                    <jats:sub>4<\/jats:sub>\n                    receptor agonist. We assessed effects of Velusetrag on gastrointestinal transit and compared its pharmacokinetics in healthy volunteers (HV) and chronic constipation (CC) patients. Sixty HV were randomly assigned, double\u2010blind to placebo, 5, 15, 30 or 50\u2003mg Velusetrag (single and 6\u2010day dosing). Primary endpoints were colonic transit (geometric centre at 24\u2003h, GC24) and ascending colon emptying (ACE)\n                    <jats:italic>T<\/jats:italic>\n                    <jats:sub>1\/2<\/jats:sub>\n                    after first dose. Secondary endpoints included gastric emptying (GE)\n                    <jats:italic>T<\/jats:italic>\n                    <jats:sub>1\/2<\/jats:sub>\n                    and colonic filling at 6\u2003h (CF6). Single dose Velusetrag significantly accelerated GC24, ACE\n                    <jats:italic>T<\/jats:italic>\n                    <jats:sub>1\/2<\/jats:sub>\n                    , and CF6; 30 and 50\u2003mg Velusetrag accelerated all three endpoints. With multiple doses, Velusetrag 30\u2003mg accelerated GC24, and overall accelerated GE\n                    <jats:italic>T<\/jats:italic>\n                    <jats:sub>1\/2<\/jats:sub>\n                    at 15\u201350\u2003mg. Pharmacokinetics studies showed dose proportionality in health, and no significant differences between health and chronic constipation with a 15\u2003mg oral dose of Velusetrag. Stimulation of bowel function after15\u2003mg Velusetrag was similar in CC and controls. There were no serious adverse events; notable adverse events were the predictable gastrointestinal effects such as diarrhoea or altered bowel movements. Velusetrag significantly accelerated intestinal and colonic transit after single dosing and accelerated gastric emptying after multiple dosing. Further studies of its potential as a gastrointestinal and colonic prokinetic are warranted.\n                  <\/jats:p>","DOI":"10.1111\/j.1365-2982.2009.01378.x","type":"journal-article","created":{"date-parts":[[2009,8,18]],"date-time":"2009-08-18T21:26:55Z","timestamp":1250630815000},"page":"42","source":"Crossref","is-referenced-by-count":95,"title":["Effects of Velusetrag (TD\u20105108) on gastrointestinal transit and bowel function in health and pharmacokinetics in health and constipation"],"prefix":"10.1111","volume":"22","author":[{"given":"M. L.","family":"Manini","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Camilleri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Goldberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Sweetser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Mckinzie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Burton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Wong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. M.","family":"Kitt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y.\u2010p.","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A. R.","family":"Zinsmeister","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2009,12,9]]},"reference":[{"key":"e_1_2_7_2_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra020995"},{"key":"e_1_2_7_3_2","doi-asserted-by":"publisher","DOI":"10.1152\/ajpgi.00264.2005"},{"key":"e_1_2_7_4_2","unstructured":"http:\/\/www.fda.gov\/bbs\/topics\/NEWS\/2007\/NEW01597.html: accessed 3\/15\/2008."},{"key":"e_1_2_7_5_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjp.0705929"},{"key":"e_1_2_7_6_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.2005.40749.x"},{"key":"e_1_2_7_7_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1542-3565(04)00356-8"},{"key":"e_1_2_7_8_2","first-page":"A687","article-title":"TD\u20105108, a selective, high intrinsic activity 5\u2010HT4 receptor agonist \u2010 in vitro profile at human recombinant 5\u2010HT4 receptor splice variant and human isolated colon","volume":"132","author":"Smith J","year":"2007","journal-title":"Gastroenterology"},{"key":"e_1_2_7_9_2","first-page":"A688","article-title":"The in vivo preclinical profile of TD\u20105108, a selective, high intrinsic activity 5\u2010HT4 receptor agonist","volume":"132","author":"Beattie DT","year":"2007","journal-title":"Gastroenterology"},{"key":"e_1_2_7_10_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0025-6196(12)62169-7"},{"key":"e_1_2_7_11_2","first-page":"A374","article-title":"In healthy subjects, TD\u20105108, a selective high intrinsic activity 5\u2010HT4 receptor agonist, shows dose\u2010proportional pharmacokinetics and exhibits a profile consistent with once\u2010daily dosing","volume":"132","author":"Wong SL","year":"2007","journal-title":"Gastroenterology"},{"key":"e_1_2_7_12_2","first-page":"A60","article-title":"TD\u20105108, a selective 5\u2010HT4 agonist with high intrinsic activity, shows immediate and sustained prokinetic activity in healthy subjects","volume":"132","author":"Goldberg MR","year":"2007","journal-title":"Gastroenterology"},{"key":"e_1_2_7_13_2","first-page":"1807","article-title":"Colonic transit scintigraphy labeled activated charcoal compared with ion exchange pellets","volume":"38","author":"Burton DD","year":"1997","journal-title":"J Nucl Med"},{"key":"e_1_2_7_14_2","doi-asserted-by":"publisher","DOI":"10.1152\/ajpgi.1989.257.2.G284"},{"key":"e_1_2_7_15_2","doi-asserted-by":"publisher","DOI":"10.1016\/0016-5085(92)91092-I"},{"key":"e_1_2_7_16_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF01297027"},{"key":"e_1_2_7_17_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2036.2002.01344.x"},{"key":"e_1_2_7_18_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2982.2006.00865.x"},{"key":"e_1_2_7_19_2","doi-asserted-by":"publisher","DOI":"10.3109\/00365529709011203"},{"key":"e_1_2_7_20_2","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2007.06.067"},{"key":"e_1_2_7_21_2","doi-asserted-by":"publisher","DOI":"10.1016\/0016-5085(78)90246-9"},{"key":"e_1_2_7_22_2","doi-asserted-by":"publisher","DOI":"10.1016\/0016-5085(93)90941-5"},{"key":"e_1_2_7_23_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2982.2005.00715.x"},{"key":"e_1_2_7_24_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2036.2001.01103.x"},{"key":"e_1_2_7_25_2","doi-asserted-by":"publisher","DOI":"10.1136\/gut.44.5.682"},{"key":"e_1_2_7_26_2","doi-asserted-by":"publisher","DOI":"10.1053\/gast.2001.21166"},{"key":"e_1_2_7_27_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0800670"},{"key":"e_1_2_7_28_2","first-page":"A547","article-title":"TD\u20105108, a selective 5\u2010HT4 agonist, is consistently better than placebo regardless of response definition in patients with chronic constipation","volume":"133","author":"Goldberg MR","year":"2008","journal-title":"Gastroenterology"},{"key":"e_1_2_7_29_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1476-5381.2008.00007.x"}],"container-title":["Neurogastroenterology &amp; Motility"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2982.2009.01378.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1365-2982.2009.01378.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,14]],"date-time":"2023-10-14T02:25:16Z","timestamp":1697250316000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1365-2982.2009.01378.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,12,9]]},"references-count":28,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2010,1]]}},"alternative-id":["10.1111\/j.1365-2982.2009.01378.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1365-2982.2009.01378.x","archive":["Portico"],"relation":{},"ISSN":["1350-1925","1365-2982"],"issn-type":[{"value":"1350-1925","type":"print"},{"value":"1365-2982","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,12,9]]}}}